Leadership Team

Kimberly Kelly, PhD founded and has led ZielBio for 5 years, currently serving as President. Dr. Kelly is a biomedical engineer specializing in therapeutic target identification. She trained at Hamilton College in Chemistry before receiving her PhD at the Huntsman Cancer Institute at the University of Utah. Dr. Kelly did a postdoctoral fellowship at Massachusetts General Hospital before becoming a Full Professor of Biomedical Engineering at the University of Virginia.  Dr. Kelly serves as reviewer and is on the editorial board of numerous scientific journals, including Molecular Imaging and Biology, Cancer Research, and as the President of the Center for Molecular Imaging Innovation and Translation in SNMMI. A frequent lecturer, she has published over 65 scientific manuscripts and is the inventor of over 20 granted patents and patent applications.

Prior to joining ZielBio, Anne Heldreth served as Vice President, Business Planning and Operations at Cavion, Inc. (acquired by Jazz Pharmaceuticals, Inc). She was an Associate practicing in the areas of securities and mergers & acquisitions at Cleary, Gottlieb, Steen & Hamilton and Law Clerk to the Honorable Richard J. Cardamone of the US Court of Appeals for the Second Circuit. She has had extensive legal, research and administrative experience both as an attorney and volunteer. Ms. Heldreth received her JD from The Cornell Law School and BA from St. John’s College (Annapolis).